Calidi Biotherapeutics, Inc. (CLDI) AMEX

1.24

-0.08(-6.06%)

Updated at February 05 09:56AM

Currency In USD

Valuation

Market Cap254.99M
Enterprise Value260.18M
P/E Ratio-0.48
PEG Ratio-0.04
Price/Sales Ratio0
Price/Book Ratio-1
Enterprise/Revenue0
Enterprise/EBITDA-1.74

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-3.24
Return On Equity1.93

Income Statement

Revenue0
Revenue/Share0
Gross Profit-1.26M
EBITDA-27.58M
Net Income-29.22M
Diluted EPS-17.3

Balance Sheet

Total Cash1.9M
Total Cash/Share0.24
Total Debt9.02M
Total Debt/Equity-0.88
Current Ratio0.19
Book Value Per Share-1.25

Price History

52-Week Change-82.4
52-Week High16.8
52-Week Low0.58
Moving Average 50 Days1.44
Moving Average 200 Days1.6

Statistics

Average Volume2.01M
Shares Outstanding25.92M
% Held by Institutions4.74

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJuly 15, 2024